# Doceree

> Doceree supplies healthcare advertising and engagement technology to pharmaceutical manufacturers, life sciences brands, agencies, medical publishers, EHR platforms and health systems. Its proprietary HCP identity technology and clinical-context integrations support programmatic messaging, publisher monetization, AI-assisted brand engagement and measurement toward prescription fill and refill.

- **Founded:** 2019
- **Headquarters:** Short Hills, United States
- **Founders:** Harshit Jain (Founder & Global CEO), Daleep Manhas (Co-founder (historically reported); current role unconfirmed), Kamya Elawadhi (Co-Founder & President; elevated February 2026)
- **Products:** Espyian, Clinical Intent Signals, AdManager, Spark, Doceree Nudges
- **Notable:** Raised a USD 35 million Series B in September 2023., Launched programmatic point-of-care messaging in January 2021., Launched Spark at HIMSS 2024.

## Products & services

- **Espyian** — Proprietary deterministic HCP identity graph supporting verified physician targeting across clinical and publisher environments.
- **Clinical Intent Signals** — Clinical-context and professional engagement signals used to inform audience selection, timing and activation.
- **AdManager** — Healthcare publisher ad monetization, inventory management, HCP identification, campaign delivery and reporting.
- **Spark** — Point-of-care messaging infrastructure for EHR and related platforms, using clinical triggers to surface therapy education, affordability support and trial opportunities.
- **Doceree Nudges** — AI-assisted, context-sensitive HCP messaging designed to reduce irrelevant promotion and fit clinical workflows.
- **Account-based Marketing** — Life sciences campaigns targeting HCP groups associated with healthcare institutions and accounts.
- **Marketplace** — Buying and activation workspace connecting healthcare advertisers to channels, audiences and partner offerings.
- **RepTwin** — AI-powered virtual brand representative designed to extend approved brand engagement between or beyond field-force visits.
- **Publisher AI Suite** — Publisher tools for editorial AI assistants, bot defense, content licensing and advertising in AI interfaces.
- **co-pay.com** — Patient affordability and access workflow offering savings delivery, consent-based enrollment, prior authorization assistance and therapy-start reporting.
- **Daily Command** — AI-assisted pharma marketing workspace for intelligence, planning, activation and measurement; public release dated July 14, 2026 by Doceree.

## Achievements

- Raised a USD 35 million Series B in September 2023.
- Launched programmatic point-of-care messaging in January 2021.
- Launched Spark at HIMSS 2024.
- Reported more than 4,000 campaigns and over 5 million HCPs engaged in 2023.
- Reported a network of 185+ EHR/health-system and 2,000+ medical publisher integrations on its current site.
- Named as a vendor in the 2026 Gartner Hype Cycle for Life Science Enterprise Technologies, according to Doceree’s announcement; this is not a Gartner endorsement.
- Daily Command public release dated July 14, 2026 following industry co-creation and a five-partner beta.

## Latest updates

- **2026-02** — Kamya Elawadhi elevated to Co-Founder & President.
- **2026-05** — Daily Command unveiled at the May 7 Health Decode Makers Summit in New York with 75 industry participants.
- **2026-07** — Daily Command listed as publicly live from July 14.
- **2026-09** — Company blog continued publishing on clinical-intent targeting and measuring HCP campaign impact, including a September 24 post.

## Links

- Website: https://doceree.com/
- LinkedIn: https://www.linkedin.com/company/doceree
- Twitter/X: https://x.com/doceree
- YouTube: https://www.youtube.com/@doceree838
- Facebook: https://www.facebook.com/doceree/

---

Profile page: https://yespress.io/doceree
Published by YesPress — https://yespress.io
Last updated: 2026-10-02